At TCS, we don’t just help businesses transform. We help them become perpetually adaptive enterprises, built to evolve continuously and confidently in a world of constant change.
Whether it’s running a marathon or helping businesses thrive in applying new technology innovations at scale, we understand what it takes to keep pushing the limits of what’s possible.
We are a digital transformation and technology partner of choice for industry-leading organizations worldwide.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
At TCS, we help enterprises grow through innovative solutions globally. Adapt and thrive with us.
TCS IN THE NEWS
You have these already downloaded
We have sent you a copy of the report to your email again.
By SriJyothsna Yeleswarapu, Aditya Rao, Thomas Joseph, Vangala Govindakrishnan Saipradeep and Rajgopal Srinivasan, TCS
A research paper by TCS experts titled "A pipeline to extract drug-adverse event pairs from multiple data sources" was published in the reputed industry journal BMC Medical Informatics and Decision Making.
Pharmacovigilance aims to uncover and understand harmful side-effects of drugs, termed adverse events (AEs). Although the current process of pharmacovigilance is very systematic, the increasing amount of information available in specialized health-related websites as well as the exponential growth in medical literature presents a unique opportunity to supplement traditional adverse event gathering mechanisms with new-age ones.
The paper presents a semi-automated pipeline to extract associations between drugs and side effects from traditional structured adverse event databases as well as from non-traditional sources such as text from MEDLINE abstracts .
Read the complete paper here.